ReviewInfection and immunity2026
Implications of bacterial exposure to reactive oxygen and chlorine species.
Review in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Synergy Between a Silver-Ruthenium Antimicrobial and Aminoglycosides Is Based on Severe Macromolecular Damage.Molecular microbiology · 2026Article
- Redox biology underlying the efficacy and toxicity of colistin as a last-resort antibiotic.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
To inhabit aerobic environments, microbes must be able to cope with the reactive byproducts of aerobic growth. These toxic compounds, also named reactive oxygen species (ROS), damage a variety of cellular macromolecules, and thus demand universal adaptive responses in microorganisms. Beyond ROS, microbes must also contend with exogenous oxidants such as reactive chlorine species (RCS) and reactive nitrogen species (RNS). In the context of antimicrobial activity, discussions on exogenous reactive species have typically focused on pathogen clearance during the oxidative burst of activated leukocytes. However, the discovery that oxidative stress may contribute to the activity of bactericidal antibiotics presents new possibilities for targeting the antioxidant defenses of pathogens as an antimicrobial strategy for potentiating current antibiotics. Considering the emergence of antibiotic resistance in many clinically relevant bacteria, and the concurrent decline in antibiotic discovery efforts, such alternative treatment options are increasingly needed. In this minireview, we discuss the well-established pathways of oxidative stress resulting from endogenous and exogenous sources of ROS and RCS. We also contrast the macromolecular targets of ROS and RCS, as well as specialized detoxification mechanisms evolved by bacteria to minimize damage caused by each species. The implications of ROS/RCS exposure are then discussed in two facets: their contributions to antibiotic resistance and involvement in the activity of bactericidal antibiotics. Finally, we highlight antimicrobial strategies whose mode of action is proposed to depend on or involve ROS formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.